Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 12;26(4):647-653.
doi: 10.5603/RPOR.a2021.0076. eCollection 2021.

Palliative brachytherapy to axilla and hypopharynx in elderly patient with hypopharyngeal squamous cell carcinoma - case report

Affiliations
Case Reports

Palliative brachytherapy to axilla and hypopharynx in elderly patient with hypopharyngeal squamous cell carcinoma - case report

Gokula Kumar Appalanaido et al. Rep Pract Oncol Radiother. .

Abstract

Brachytherapy (BT) is an important local treatment of tumor and it can be applied to different anatomical sites either in a curative or palliative setting. BT can deliver large dose of radiation to the tumor while sparing the surrounding normal tissue which translates into a better therapeutic ratio compared to external beam radiotherapy. However, the evidence for the use of brachytherapy in the palliative setting is lacking in the literature. In this case report, we describe the brachytherapy technique and outcome of a patient with squamous cell carcinoma of the hypopharynx who underwent palliative brachytherapy to the hypopharynx and metastatic tumor at the right axilla.

Keywords: axilla; brachytherapy; elderly; hypopharynx; squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors have no conflict of interest to disclose.

Figures

Figure 1
Figure 1
12 × 7 cm foul smelling fungating lesion at the right axilla
Figure 2AB
Figure 2AB
Axial slice of CT showing extensive right axilla lesion involving the chest wall and right arm
Figure 3
Figure 3
15 applicators were used to cover the marked tumour area sufficiently
Figure 4
Figure 4
Final isodose plan after optimization
Figure 5
Figure 5
One-week post treatment, the axillary fungating mass had flattened and there was no more spontaneous bleeding
Figure 6
Figure 6
The axillary tumour site showed telangiactesia at the periphery and slough covered cavity with no significant pain or active bleeding
Figure 7A
Figure 7A
The isodoses were normalized and adjusted graphically as to have the 100% isodose covering 1 cm depth laterally from the from the centre of the applicator; B. Due to the geographical position of the tumor, 0.5 cm safety margin superiorly and 1.5 cm inferiorly of the gross tumor volume (GTV) was assigned

References

    1. Martin JM, Handorf EA, Kutikov A, et al. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014;120(14):2114–2121. doi: 10.1002/cncr.28697. - DOI - PMC - PubMed
    1. Gill BS, Lin JF, Krivak TC, et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. Int J Radiat Oncol Biol Phys. 2014;90(5):1083–1090. doi: 10.1016/j.ijrobp.2014.07.017. - DOI - PubMed
    1. Homs MYV, Steyerberg EW, Eijkenboom WMH, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364(9444):1497–1504. doi: 10.1016/S0140-6736(04)17272-3. - DOI - PubMed
    1. Skowronek J. Current status of brachytherapy in cancer treatment — short overview. J Contemp Brachytherapy. 2017;9(6):581–589. doi: 10.5114/jcb.2017.72607. - DOI - PMC - PubMed
    1. Skowronek J, Piotrowski T, Młynarczyk W, et al. Advanced tracheal carcinoma — a therapeutic significance of HDR brachytherapy in palliative treatment. Neoplasma. 2004;51(4):313–318. - PubMed

Publication types

LinkOut - more resources